# 11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues

> **NCT01783002** · PHASE2 · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 50 (estimated)

## Conditions studied

- Primary Hyperparathyroidism

## Interventions

- **RADIATION:** 11C-Methionine PET/CT scanning
- **RADIATION:** 18F-FDG PET/CT scanning
- **RADIATION:** SPECT-CT scanning

## Key facts

- **NCT ID:** NCT01783002
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2018-03
- **Final completion:** 2018-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2015-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01783002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01783002, "11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01783002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*